Sign in

    Bunge Global SA (BG)

    Q4 2024 Earnings Summary

    Reported on Feb 20, 2025 (Before Market Open)
    Pre-Earnings Price$75.02Last close (Feb 4, 2025)
    Post-Earnings Price$71.26Open (Feb 5, 2025)
    Price Change
    $-3.76(-5.01%)
    • Expected Synergies and Growth from Acquisitions: Bunge is poised to benefit from its upcoming business combination with Viterra and the acquisition of CJ Selecta. The integration is expected to bring significant commercial synergies, strengthening the business and providing cash for further investments. The CJ Selecta acquisition is anticipated to generate mid-teen returns over the long term. ,
    • Improved Performance in South America: After a challenging year in 2024, operating conditions in South America are stabilizing, and Bunge expects significant improvement in the region in 2025. This should positively impact margins in origination, crush, and exporting across their systems in beans and corn. , ,
    • Upside Potential from Biofuel Demand and Policy Clarity: Bunge has significant underutilized capacity in biofuels, renewable diesel, and sustainable aviation fuel. With expected policy clarity around the Renewable Volume Obligation (RVO) and tax credits like 45Z, there is potential for increased demand for soybean oil. This could lead to higher utilization of their installed capacity and support agricultural demand at the farm gate. ,
    • The company provided a 2025 adjusted EPS outlook of approximately $7.75, which is lower than prior years and suggests potential earnings decline.
    • Uncertainties in U.S. biofuel policies are leading to decreased demand for soybean oil, impacting the Refined and Specialty Oils segment. The company noted that "demand has been soft with all the uncertainty", which could continue to negatively affect margins.
    • The acquisition of Viterra might not provide immediate financial benefits, as the company indicated it could be "neutral to slightly positive" in the first year, and synergies may take time to realize, which could pressure earnings in the near term.
    MetricYoY ChangeReason

    Total Revenue

    -9.3%

    Total Revenue fell from $14,936 million in Q4 2023 to $13,542 million in Q4 2024, reflecting a significant decline likely driven by continued pricing pressures and softening volumes in key segments compared to the previous period.

    Operating Income (EBIT)

    Not explicitly provided YoY

    Despite the revenue decline, Operating Income of $767 million in Q4 2024 suggests that effective cost management and margin discipline helped mitigate top‐line pressures relative to prior periods.

    Net Income

    Relatively flat

    Net Income remained stable at $653 million despite lower revenue, indicating that cost controls and possibly a beneficial mix of lower operating expenses helped sustain profitability from Q4 2023 into Q4 2024.

    Earnings per Share

    Stable

    EPS stability at $4.32 (basic) and $4.26 (diluted) demonstrates that the company maintained its profitability per share through consistent margin management and financial discipline, even as revenue declined from the previous period.

    MetricPeriodPrevious GuidanceCurrent GuidanceChange

    Adjusted EPS

    FY 2025

    no prior guidance

    ~$7.75

    no prior guidance

    Adjusted Annual Effective Tax Rate

    FY 2025

    no prior guidance

    21% to 25%

    no prior guidance

    Interest Expense

    FY 2025

    no prior guidance

    $250 million to $280 million

    no prior guidance

    Capital Expenditures (CapEx)

    FY 2025

    no prior guidance

    $1.5 billion to $1.7 billion

    no prior guidance

    Depreciation and Amortization

    FY 2025

    no prior guidance

    $490 million

    no prior guidance

    MetricPeriodGuidanceActualPerformance
    Capital Expenditures
    FY 2024
    $1.2 billion to $1.4 billion(upper end)
    $1.376 billion
    Met
    1. 2025 Guidance Details
      Q: What are the puts and takes in the 2025 guidance?
      A: Management acknowledged less visibility due to trade disruptions and U.S. biofuel policy uncertainty, specifically 45Z. They expect a constructive global oil supply and demand, with soy taking a bigger share of global flows. Improvement is expected in Brazil and Argentina, but lower margins in North America and Europe are anticipated. The 2025 guidance does not factor in Viterra, CJ Selecta, or share repurchases.

    2. Earnings Guidance vs. Mid-Cycle Outlook
      Q: How does the 2025 guidance compare to the $850 million mid-cycle outlook?
      A: Processing margins are steady, but volumes are down due to impacts in Ukraine, sale of Russia business, and less tolling in South America. Merchandising profits are assumed lower, at $50–75 million per quarter versus $100 million previously. Higher interest expenses are offset by share buybacks. Refined and Specialty Oils margins are better than anticipated.

    3. Viterra and CJ Selecta Acquisitions Impact
      Q: What are the financial implications of Viterra and CJ Selecta acquisitions?
      A: The Viterra acquisition is expected to be neutral to slightly positive in year one, with commercial synergies taking time to realize. For CJ Selecta, management expects mid-teen returns on the $600 million acquisition, contributing about $60 million EBIT.

    4. Viterra Regulatory Approval Progress
      Q: Update on Viterra's regulatory approval, especially with China?
      A: Management reported productive discussions with Chinese authorities, reaching later stages of the process. Long-term relationships with China remain strong, and U.S.-China tariffs haven't affected the discussions.

    5. Future Earnings Trajectory
      Q: How will earnings evolve over the next few years?
      A: Management expects to grow earnings from the 2025 base, benefiting from the Viterra integration and realizing commercial synergies. Growth CapEx projects are on track, anticipated to contribute about $2.50 to EPS, resetting the baseline to $11 assuming mid-cycle conditions.

    6. Growth CapEx Returns
      Q: What returns are expected from growth CapEx investments?
      A: Growth projects are expected to contribute about $2.50 to EPS once completed around 2026. The investments are proceeding largely as planned, with some timing adjustments.

    7. Crush Margin Uncertainties
      Q: What's the outlook amid near-term crush margin uncertainties?
      A: Management anticipates a tougher first quarter but expects improvement in the second half. They forecast 40% of 2025 earnings in the first half, with only 40% of that in Q1. Policy clarity on renewable fuels could positively impact margins.

    8. Potential Trade Tariffs Impact
      Q: How could tariffs or trade policy changes affect the business?
      A: Management believes their balanced global footprint positions them well to manage regional trade-offs. They are accustomed to adjusting supply flows between North and South America based on trade dynamics.

    9. Refining Margins Outlook
      Q: Where will refining margins settle once demand returns?
      A: Refining premiums have held up well due to elastic food industry demand. Potential upside exists if biofuel policies become clearer, boosting soybean oil demand.

    10. South America Take-or-Pay Timing
      Q: Was the take-or-pay impact in South America centered in first or second half of 2024?
      A: The impact was felt throughout 2024, affecting margins across origination, crush, and exporting, accelerating in Q4.